Alkaloid AD SkopjeXMAE:ALK -0.41%84 Gross Margin % is 47.35% as of Mar. 2026, which is 5% above its 10-year median of 45.16. GuruFocus rates XMAE:ALK with a GF Score™ of 84/100 and a GF Value™ of MKD27,166.15 (Modestly Undervalued). Among 935 Drug Manufacturers companies, Alkaloid AD Skopje ranks worse than 54.76% on this metric.
The historical rank and industry rank for Alkaloid AD Skopje's Gross Margin % or its related term are showing as below:
XMAE:ALK'
s Gross Margin % Range Over the Past 10 Years
Min: 44.62 Med: 45.16 Max: 46.19
Current: 45.81
During the past 13 years, the highestGross Margin % of Alkaloid AD Skopje was 46.19%. The lowest was 44.62%. And the median was 45.16%.
XMAE:ALK's Gross Margin % is ranked worse than 54.76% of 935
companies
in the Drug Manufacturers industry
Industry Median: 48.54
vs XMAE:ALK: 45.81
Alkaloid AD Skopje had a gross margin of 47.35% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Alkaloid AD Skopje was 0.20% per year.
Alkaloid AD Skopje (XMAE:ALK) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Alkaloid AD Skopje had a gross margin of 47.35% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Alkaloid AD Skopje Gross Margin % Related Terms
Alkaloid AD Skopje Gross Margin % Historical Data
* Premium members only.
The historical data trend for Alkaloid AD Skopje's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XMAE:ALK vs ZTS, UTHR, VTRS: Gross Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Alkaloid AD Skopje's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alkaloid AD Skopje Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Alkaloid AD Skopje's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Alkaloid AD Skopje's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Alkaloid AD Skopje (XMAE:ALK) has a Gross Margin % of 47.35% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Alkaloid AD Skopje and its competitors. This is near median its historical median of 45.16. Over the past decade, Alkaloid AD Skopje's Gross Margin % has ranged from 44.62 to 46.19. According to the industry distribution chart, Alkaloid AD Skopje ranks #512 out of 935 companies in the Drug Manufacturers industry, placing it in the top 54.8%.
Is Alkaloid AD Skopje's Gross Margin % too high?
Alkaloid AD Skopje's current Gross Margin % of 47.35% is near median its 10-year median of 45.16. Over the past 10 years, this metric has ranged from a low of 44.62 to a high of 46.19. The Drug Manufacturers industry median Gross Margin % is 48.54. Alkaloid AD Skopje's value of 47.35% is 2.5% below this industry median. Based on the distribution chart, Alkaloid AD Skopje ranks #512 out of 935 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Alkaloid AD Skopje has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alkaloid AD Skopje's Gross Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Alkaloid AD Skopje ranks #512 out of 935 companies for Gross Margin %. This places Alkaloid AD Skopje in the lower half of its industry. The industry median Gross Margin % is 48.54. Alkaloid AD Skopje's value of 47.35% is 2.5% below this benchmark. Historically, Alkaloid AD Skopje's own Gross Margin % has ranged from 44.62 to 46.19 over the past decade. While the company's 10-year median is 45.16 vs. the industry median of 48.54, Alkaloid AD Skopje has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 935 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alkaloid AD Skopje's current Gross Margin % of 47.35% is 2.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Alkaloid AD Skopje and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alkaloid AD Skopje's current Gross Margin % is 47.35%, which is near median its own 10-year median of 45.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alkaloid AD Skopje stock overvalued right now?
Based on GuruFocus' analysis, Alkaloid AD Skopje (XMAE:ALK) is currently considered Modestly Undervalued. The stock's GF Value™ is MKD27,166.15, compared to a current price of MKD24,200.00 — trading 10.9% below its estimated fair value. The current Gross Margin % is 47.35%, which is near median its 10-year median of 45.16 and 2.5% below the Drug Manufacturers industry median of 48.54. Alkaloid AD Skopje's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Alkaloid AD Skopje (XMAE:ALK), the current Gross Margin % is 47.35% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alkaloid AD Skopje (XMAE:ALK) Overvalued in 2026?
Based on GuruFocus' analysis, Alkaloid AD Skopje stock appears to be undervalued.
The current stock price of MKD24,200.00 is trading 10.9% below its estimated GF Value™ of MKD27,166.15.
GuruFocus considers Alkaloid AD Skopje to be Modestly Undervalued.
Key valuation signals for XMAE:ALK:
Gross Margin %: 47.35% (near median its 10-year median of 45.16)
GF Value™: MKD27,166.15 vs. price of MKD24,200.00 (10.9% below fair value)
Industry Position: 2.5% below the Drug Manufacturers median (#512 of 935)
No single metric tells the full story. See the XMAE:ALK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alkaloid AD Skopje is engaged in producing and selling pharmaceutical, chemical and cosmetic products, as well as goods from the herbal origin. Its segments are Pharmaceuticals, Chemicals, Cosmetics and Botanicals. It derives maximum revenue from Pharmaceuticals products segment.
84GF Score
Get the complete analysis for XMAE:ALK
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XMAE:ALK has been successfully added to your 
